Key takeaways Mounjaro is approved for type 2 diabetes, while Wegovy is approved for weight loss In clinical trials, patients taking tirzepatide (the active ingredient in Mounjaro) lost more weight on average than those taking semaglutide (the active ingredient in Wegovy) Both drugs have similar gastrointestinal side effects, but prices vary depending on your insurance status Mounjaro (tirzepatide) and Wegovy (semaglutide) are two medications that have gained a lot of attention in recent years
This information should be interpreted with your qualified healthcare provider as one factor among manymedical history, current medications, and baseline metabolic markers matter equally in personalizing your treatment plan
Lower GLP-1 equals increased appetite and weight gain
Adurty, Prateek Grade: 7 Sewickley Academy, Sewickley, PA Project Title: Going Green: Environmental Impact of Fuels by Combustion Aggarwal, Dhruv Grade: 8 Medea Creek Middle School, Oak Park, CA Project Title: Wi-Tricity: Wireless Electricity Using Resonant Inductive Coupling Aiellp, Jose Grade: 6 Falk School, Pittsburgh, PA Project Title: Its Not All Trash Talk
Never split branded pens like Mounjaro or Zepbound
As semaglutide is yet to be officially launched, it would not be appropriate to refer to or publish any name as the brand name at this stage, a Dr Reddys spokesperson said in an email
